News
Astellas and Seagen Announce Positive Topline Results from Second...
Astellas Pharma Inc. and Seagen Inc. announced positive topline results from the second cohort of patients in the pivotal phase 2 single-arm clinical trial known...
News
Merck Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara...
Merck, a leading science and technology company, announced that it has signed agreements licensing its CRISPR technology to two companies — PanCELLa, a cell therapy...
News
Direct Biologics Granted Expanded Access by FDA for ExoFlo...
Direct Biologics, LLC, announced that the FDA has granted expanded access for ExoFlo in the treatment of patients with COVID-19 associated acute respiratory distress syndrome...
Clinical Trials
Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances...
AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and outside the...
News
Gilead Sciences signs joint procurement agreement with the European...
Gilead Sciences and the EC signed a joint procurement agreement (JPA) that will enable rapid and equitable access to Veklury® (remdesivir), the first antiviral drug...
News
Regeneron’s REGN-COV2 antibody cocktail reduced viral levels and improved...
Regeneron Pharmaceuticals, Inc. announced the first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 showing it...
News
BryoLogyx Announces Completion of World’s First GMP Synthesis of...
BryoLogyx, Inc., announced that it has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good Manufacturing Practice (GMP) regulations. Bryostatin-1 is the company’s lead...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.